منابع مشابه
Dosages involving splitting tablets: common but unnecessary?
Objectives Prescribing of treatments with dosages involving split tablets is common. Many patients report they have difficulties in dividing the tablets and in following the prescribed treatment. The objective of this study was to examine to what extent dosages involving split tablets are prescribed in Sweden. Methods The dosage text strings were analysed on prescriptions dispensed during one m...
متن کاملInfluence of splitting on dissolution properties of metoprolol tablets.
The objective of this work was to compare several profiles of dissolution data for metoprolol controlled release tablet formulations in order to identify possible changes in dissolution profiles of whole and scored tablets. Adequate design of score lines (on one or both sides) as well as the technology of preparation of tablet mixtures ensure forming a score line of adequate thickness, shape, s...
متن کاملInfluence of tablet splitting on content uniformity of lisinopril/hydrochlorthiazide tablets.
Dose-related adverse effects of medications are a major problem in modern medical practice. The "correct" dose, based on drug company guidelines in package inserts, may not be correct for many patients. Tablet splitting or dividing has been an accepted practice for many years as a means of obtaining the prescribed dose of medication. As model tablets for this investigation, two batches of lisin...
متن کاملTrecator®(ethionamide tablets, USP)Tablets
Ethionamide is a yellow crystalline, nonhygroscopic compound with a faint to moderate sulfide odor and a melting point of 162°C. It is practically insoluble in water and ether, but soluble in methanol and ethanol. It has a partition coefficient (octanol/water) Log P value of 0.3699. Trecator tablets contain 250 mg of ethionamide. The inactive ingredients present are croscarmellose sodium, FD&C ...
متن کاملDEPAKOTE® Tablets DIVALPROEX SODIUM DELAYED-RELEASE TABLETS
BOX WARNING: HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALPROIC ACID AND ITS DERIVATIVES. EXPERIENCE HAS INDICATED THAT CHILDREN UNDER THE AGE OF TWO YEARS ARE AT A CONSIDERABLY INCREASED RISK OF DEVELOPING FATAL HEPATOTOXICITY, ESPECIALLY THOSE ON MULTIPLE ANTICONVULSANTS, THOSE WITH CONGENITAL METABOLIC DISORDERS, THOSE WITH SEVERE SEIZURE DISORDERS ACCOMPANIE...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2003
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.2003.019